Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Jim Cramer Slams Sempra SRE After Disappointing Quarter

May 17, 2025
Sempra, a leading energy company, faced criticism from financial guru Jim Cramer after reporting a disappointing quarter. Despite this setback, Sempra recently declared a common dividend for its shareholders. The company's stock, NYSE:SRE, continues to be a topic of interest on Wall Street. For the latest updates and forecasts on Sempra's stock movement, consult the professionals at Stocks Prognosis.
If you want to leave a comment, then you need Login or Register





Other data for SRE

Related data

SREApril 28, 2025SEMPRA Stock Hits Forecast Price Target With 14.75% Profit: QuantWave Analysis  ~1 min.

On April 4, 2025, QuantWave's automated forecasting platform signaled a long position for SEMPRA stock at a price of $65.31....

SREApril 25, 2025SEMPRA Stock Hits Forecast Price Target with 13.36% Profit Gain  ~2 min.

On April 4th, 2025, QuantWave, the automated forecasting platform, issued a bullish signal for SEMPRA stock with a price target of $74.68. The initial price at the time of the signal was $65....

SREMarch 14, 2025Is Sempra SRE the Most Undervalued Utility Stock to Invest in Now?  ~2 min.

Recently, there has been a lot of speculation regarding Sempra Energy (SRE) and its potential as an investment opportunity....

SREFebruary 27, 2025Sempra Energy Faces Challenges After Q4 Miss, But Will It Bounce Back?  ~2 min.

Sempra Energy (NYSE:SRE) faced a setback recently as it reported a Q4 miss in its guidance, which led to a decline in its share value....

SREFebruary 26, 2025SEMPRA ENERGY Reports Quarterly Earnings: SRE Shares Surge  ~1 min.

SEMPRA ENERGY (SRE), a leading energy company, recently released its quarterly earnings report, showcasing strong financial performance....

SREFebruary 25, 2025QuantWave Successfully Hits Forecast Price Target for SEMPRA, Generating 18.34% Profit  ~1 min.

In the ever-fluctuating world of stock markets, accurate forecasting is key to success....

SREFebruary 25, 2025SEMPRA Stock Hits Forecast Target with an 18.34% Profit: QuantWave Analysis  ~1 min.

On January 21, 2025, QuantWave's automated forecasting platform issued a short signal for SEMPRA stock when it was trading at 84.99 $....

SREFebruary 23, 2025Sempra's Strong Earnings and Insider Selling Raise Investors' Eyebrows  ~2 min.

As Sempra (NYSE:SRE) prepares to release its latest earnings report, investors are keeping a close eye on the company's performance. Analysts are expecting an earnings per share (EPS) of $1....

SREFebruary 21, 2025Sempra Continues to Impress Investors with Strong Returns  ~1 min.

Investors in Sempra (NYSE:SRE) have seen impressive returns over the past three years, with a respectable 36% increase....

SREFebruary 10, 2025Stratos Wealth Partners LTD. Grows Stake in Sempra NYSE:SRE  ~2 min.

Stratos Wealth Partners LTD., a leading wealth management firm, has announced a significant increase in their stake in Sempra Energy (NYSE:SRE)....

PEPJanuary 12, 2025PepsiCo Inc. Faces Disappointing Earnings Growth despite Promising Projections  ~1 min.

Investors in PepsiCo Inc. (NASDAQ:PEP) have been left disappointed as the projected 1.5% earnings growth over the past three years has not translated into substantial gains....

BBYJanuary 4, 2025Best Buy NYSE:BBY Shareholders Suffer Losses Over the Past Three Years  ~1 min.

According to recent reports, investors in Best Buy Co. Inc. NYSE:BBY have experienced a decline in their investments over the past three years....

LLYNovember 2, 2024Eli Lilly stock tumbles on Q3 miss  ~1 min.

Eli Lilly and Company, a global pharmaceutical giant, experienced a significant drop in its stock value following the release of its Q3 earnings report....

LLYJanuary 28, 2025Eli Lilly and Company Shares Fall After GLP-1 Sales Miss Expectations  ~1 min.

Investors were left disappointed as Eli Lilly and Company (LLY) reported lower-than-expected sales of their GLP-1 diabetes drugs....

BBYJanuary 1, 2025Best Buy Co. Inc. Continues to Attract Interest as Brokers Recommend Moderate Buy  ~1 min.

Best Buy Co. Inc. (NYSE: BBY) has recently caught the attention of investors as it receives a consensus recommendation of moderate buy from brokerages....